January 8, 2026

Hidden blood mutations linked to higher heart disease risk after cancer treatment

January 8, 2026 / Research update / InnovateMed Author / heart disease

by Vanderbilt University Medical Center edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Credit: Pixabay/CC0 Public Domain About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood called clonal hematopoiesis of indeterminate potential (CHIP). A study by Vanderbilt Health researchers reveals that it puts them at […]

Hidden blood mutations linked to higher heart disease risk after cancer treatment Read More »

Stem cell engineering progress paves way for next-generation living drugs

January 8, 2026 / Research update / InnovateMed Author / stem cell

UBC research associate Dr. Ross Jones in the lab where they are working to develop cell-based therapies from stem cells. Credit: Phillip Chin. For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a

Stem cell engineering progress paves way for next-generation living drugs Read More »

Steroids May Lower Death Risk in Community-Acquired Pneumonia

January 8, 2026 / Research update / InnovateMed Author / pneumonia

Edited by Shreyasi Asthana November 05, 2025 TOPLINE: Adding glucocorticoids to standard care within 48 hours of hospital admission reduced the risk for death in patients with community-acquired pneumonia (CAP) in low-resource settings and was safe as an add-on to conventional therapy. METHODOLOGY: Researchers conducted a pragmatic randomized controlled trial to evaluate the efficacy and safety

Steroids May Lower Death Risk in Community-Acquired Pneumonia Read More »

Pancreatic Cancer Treatment in Transition: Chemotherapy, Genomics, and What Comes Next

January 8, 2026 / Research update / InnovateMed Author / pancreatic cancer

Emil Lou, MD, PhD DISCLOSURES January 07, 2026 Hi. I’m Dr Emil Lou, medical oncologist and specialist in gastrointestinal cancers at the University of Minnesota. It’s my pleasure to be here today to talk about all things, updates, and advances in pancreas adenocarcinoma. There are about 45,000 new cases of pancreatic cancer in the US each year, about

Pancreatic Cancer Treatment in Transition: Chemotherapy, Genomics, and What Comes Next Read More »

Restoring mitochondria shows promise for treating chronic nerve pain

January 8, 2026 / Research update / InnovateMed Author / nerve pain

by Duke University edited by Stephanie Baum, reviewed by Robert Egan Editors’ notes Credit: Pixabay/CC0 Public Domain For millions living with nerve pain, even a light touch can feel unbearable. Scientists have long suspected that damaged nerve cells falter because their energy factories known as mitochondria don’t function properly. Now, research published in Nature suggests a way forward: supplying healthy mitochondria to

Restoring mitochondria shows promise for treating chronic nerve pain Read More »

AI App Accurately Identifies Gluten-Free Packaged Foods

January 8, 2026 / Clinical Practice / InnovateMed Author / packaged food

Edited by Archita Rai December 31, 2025 TOPLINE: An artificial intelligence (AI)-powered smartphone application achieves 99% accuracy in classifying gluten-free compatibility of packaged foods, with results closely aligned with expert dietitian evaluations. METHODOLOGY: Patients with celiac disease require strict adherence to a gluten-free diet, yet inconsistent labeling and limited access to dietary expertise can hinder compliance. Researchers

AI App Accurately Identifies Gluten-Free Packaged Foods Read More »

AI Psychosis: What Physicians Should Know About Emerging Risks Linked to Chatbot Use

January 8, 2026 / Clinical Practice / InnovateMed Author / psychosis

Carla Cantor December 23, 2025 A surge in reports of psychosis-like symptoms linked to intensive chatbot use has prompted an urgent effort by researchers, physicians, and technology developers to understand how these tools may affect psychiatric vulnerabilities and how best to reduce risk. The phenomenon, often referred to as “ChatGPT psychosis” or “AI psychosis,” remains

AI Psychosis: What Physicians Should Know About Emerging Risks Linked to Chatbot Use Read More »